Joffe et al determine the efficacy and tolerability of low-dose oral 17β-estradiol and low-dose venlafaxine extended release in alleviating vasomotor symptoms. The primary outcome was the mean daily frequency of vasomotor symptoms after 8 weeks of treatment among 339 perimenopausal and postmenopausal women with at least 2 bothersome symptoms per day.
This study explores whether receipt of pharmaceutical industry-sponsored meals by physicians is associated with their prescribing the promoted brand-name drug at higher rates to Medicare beneficiaries.
This case report examines the risks associated with antidepressant use in the elderly population.
This Teachable Moment discusses the need to recognize the risks of catheter-associated trauma as an impetus for reducing the frequency of unnecessary urinary catheterization.
This Evidence to Practice report highlights the menopause guidelines recently published by the National Institute of Health and Care Excellence and suggests directions for full implementation.